CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab. - Sandoval C; Lee J; Toth B; Nagaraj R; Schauer SP; Hoffman J; Calderon E; Kollmorgen G; Sanabria Bohórquez SM; Monteiro C; Teng E; Hanson JE; et al. (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024)